Nkarta Inc

NASDAQ:NKTX   10:07:21 AM EDT
10.54
-0.32 (-2.95%)
Products

Nkarta Receives U.S. FDA Orphan Drug Designation For Nkx101 For Treatment Of Patients With AML

Published: 12/16/2021 13:22 GMT
Nkarta Inc (NKTX) - Nkarta Receives U.S. FDA Orphan Drug Designation for Nkx101 for Treatment of Patients With Aml.